Spiradenocarcinoma

Also known as: Malignant eccrine spiradenoma (morphologic abnormality) / Malignant eccrine spiradenoma of skin (disorder)

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB09035	Nivolumab	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1